Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Decide which cash back credit card you should get by assessing your spending habits. Find the best rewards for you.
9,031 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...
A practical guide to interpreting FRPH's Q2 2025 earnings transcript. Learn what to watch, how numbers fit the story,...
Alphatec (ATEC) is navigating a shifting spine device market. This guide breaks down expected 2025 earnings, key driv...
Explore how Solo Brands (SBDS) 2025 could unfold, with a clear view of revenue drivers, margins, and strategic bets. ...
As Schwab prepares to report Q4 2025 results, investors want clarity on what drives earnings and where risks lie. Thi...
In a year marked by rapid AI expansion, memory plays have emerged as a quiet engine behind stock gains. This hidden s...
AI disruption is rattling markets, but Bitcoin still has unique safeguards. This guide explains why bitcoin safe from...
As AI and cloud data reshape markets, two red-hot growth stocks 2026 could shine for bold investors. This guide break...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...